alert icon Important Updates + Notice of Vendor Data Event

Coming to a Cleveland Clinic location?
Hillcrest Cancer Center check-in changes
Cole Eye entrance closing
Visitation and COVID-19 information

Notice of MedInform data event
Learn more

Carli Lehr, MD, PhD

Carli Lehr, MD, PhD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Pulmonary Medicine
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Specialties & Treatments

Specialty in Diseases & Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • End Stage Lung Disease
  • Idiopathic Pulmonary Fibrosis
  • Pulmonary Disease
  • Pulmonary Hypertension
View all 6 Specialties +


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Carli Lehr, MD, PhD

Carli Lehr, MD, PhD is a staff pulmonologist at the Respiratory Institute and assistant professor of Medicine at the Cleveland Clinic Lerner College of Medicine, specializing in transplant medicine. She treats patients with advanced lung disease before and after lung transplantation.

Dr. Lehr is a physician scientist whose research is focused on organ allocation, statistical modeling in transplant systems, and optimizing donor selection. She holds the Gregory and Maureen Church endowed chair in Lung Transplantation Research. She currently holds a K08 grant from the National Institutes of Health to develop a donor and candidate risk prediction system to optimize lung allocation and transplant outcomes. She is the recipient of the Cystic Fibrosis Foundation Harry Shwachman Clinical Investigator Award to improve the predictive accuracy of the lung allocation score and identify cystic fibrosis-specific risk factors that impact waitlist mortality and optimize the timing of transplant for at-risk patients. Dr. Lehr serves as a co-investigator on the Cystic Fibrosis Lung Transplant Consortium which is comprised of fifteen transplant centers to advance lung transplant research for individuals with cystic fibrosis. She has also received research support from the American Society of Transplantation and the Cleveland Clinic Center for Populations Health Research.

Dr. Lehr earned her medical degree from the Ohio State University College of Medicine and completed a residency in internal medicine from Duke University. She completed fellowship training in pulmonary and critical care medicine from the Cleveland Clinic. She earned a Master of Science in Clinical Research and a Doctor of Philosophy in Clinical Translational Science from Case Western Reserve University.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Medical Education - Case Western Reserve University
Clinical Translational Science
Cleveland, OH USA

Fellowship - Cleveland Clinic
Pulmonary & Critical Care Medicine
Cleveland, OH USA

Graduate School - Case Western Reserve University
Clinical Research
Cleveland, OH USA

Residency - Duke University
Internal Medicine
Durham, NC USA

Medical Education - Ohio State University
Columbus, OH USA


  • Internal Medicine - Critical Care Medicine
  • Internal Medicine
  • Internal Medicine - Pulmonary Disease

Specialty Interests

Lung Transplant, Advanced Lung Disease

Awards & Honors

  • Fellow of the American Society of Transplantation
  • Cleveland Clinic Excellence in Teaching Award
Research & Publications

Research & Publications

See publications for Carli Lehr, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/1/2023, Dr. Lehr has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top